De Burlo Group Inc
Source: SEC Form 13F · as of Mar 2026De Burlo Group Inc holds 12 biotech & pharma companies tracked by BioSniper, totaling $58.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$58.1M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 26,518 | $24.4M |
| MCKMcKesson Corporation | 23,630 | $20.4M |
| ABBVAbbVie Inc. | 26,339 | $5.7M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 4,755 | $2.1M |
| RIOTRiot Platforms, Inc. | 111,000 | $1.4M |
| AZNASTRAZENECA PLC | 5,924 | $1.2M |
| GILDGILEAD SCIENCES, INC. | 6,133 | $855K |
| NBIXNEUROCRINE BIOSCIENCES INC | 4,667 | $615K |
| NVONovo Nordisk A/S | 16,100 | $592K |
| JNJJOHNSON & JOHNSON | 1,333 | $326K |
| ABTABBOTT LABORATORIES | 2,733 | $281K |
| AMGNAMGEN INC | 595 | $209K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.